Results 91 to 100 of about 311,439 (263)
QT Interval Prolongation in Cirrhotic Cardiomyopathy
, 2022 Amanuel Tadelle Department of Biomedical Sciences, Jimma University, Jimma City, EthiopiaCorrespondence: Amanuel Tadelle, Email newaman09@yahoo.com; amanuel.muluneh@ju.edu.etAbstract: The liver and the heart are related to each other in many aspects.
Tadelle A
core
Takotsubo Cardiomyopathy in Myasthenic Crisis
, 2020 To the Editor: We report a case series of 4 patients with Takotsubo cardiomyopathy (TC) in the setting of myasthenic crisis (see Table 1, Supplemental Digital Content 1, http://links.lww.com/JCND/A36).
Matthew Katz +11 more
core +1 more source
American Journal of Medical Genetics Part A, EarlyView.ABSTRACT Genetic modifiers of Duchenne muscular dystrophy (DMD) that alter disease severity or response to therapy have been reported using natural history or registry data sets of older corticosteroid‐treated patients. We tested associations of genetic modifiers on motor function outcomes in young (4 to < 7 years) steroid naïve clinical trial ...
Utkarsh J. Dang +16 more
wiley +1 more source
Reviews in Cardiovascular MedicineHypertrophic cardiomyopathy (HCM) is a common cardiovascular disease and one of the leading causes of exercise-induced sudden cardiac death in adolescents.
Huanhuan Ma +5 more
doaj +1 more source
The clinical characteristics of families with hypertrophic cardiomyopathy associated with mutations of cardiac myosin binding protein C [PDF]
, 2010 Introduction: Mutations in cardiac myosin binding protein-C (MYBPC3), the most common genetic cause of hypertrophic cardiomyopathy (HCM), have been reported to cause a comparatively benign and late-onset form of the disease with incomplete penetrance ...
Page, S.P.
core
, 2020 Cardiomyopathies are progressive diseases of heart muscle often caused by mutations in genes encoding sarcomeric, cytoskeletal and nucleoskeletal proteins though in many cases the cause of disease is not identified.
Ehler, E. +3 more
core +1 more source
Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry [PDF]
, 2021 Aims: Dilated cardiomyopathy (DCM) is a complex disease where genetics interplay with extrinsic factors. This study aims to compare the phenotype, management, and outcome of familial DCM (FDCM) and non-familial (sporadic) DCM (SDCM) across Europe ...
Cardiomyopathy & Myocarditis Registry Investigators Group +3 more
core
L‐Cysteine and N‐Acetylcysteine Supplementation Improves Clinical Outcome in a Patient With COXPD10
American Journal of Medical Genetics Part A, EarlyView.ABSTRACT MTO1 is a nuclear gene that encodes a mitochondrial protein essential for modifying mitochondrial transfer RNAs (tRNAs) and stabilizing codon‐anticodon interactions to ensure accurate and efficient mitochondrial protein synthesis and oxidative phosphorylation.
Nishitha R. Pillai +5 more
wiley +1 more source
Apical Hypertrophic Cardiomyopathy: A Case Report
In this case report, a patient with apical hypertrophic cardiomyopathy (AHCM) who presented to the emergency department with chest pain is presented. The symptoms, clinical findings, diagnostic methods, differential diagnosis, and treatment options for ...
Duzgun Can Senbil +2 more
core +1 more source
Diabetic Cardiomyopathy: Five Major Questions with Simple Answers [PDF]
, 2019 Diabetes is a major risk factor for heart disease. Diabetic cardiomyopathy is a long-lasting process that affects the myocardium in patients who have no other cardiac conditions.
Miguel Alejandro Rodriguez-Ramos
core +1 more source